129 related articles for article (PubMed ID: 33851489)
1. Variation in Human Research Ethics Committee and governance processes throughout Australia: a need for a uniform approach.
Dudi-Venkata NN; Cox DRA; Marson N; Tan L; Pockney P; Muralidharan V; Watson DI; Richards T;
ANZ J Surg; 2021 Nov; 91(11):2263-2268. PubMed ID: 33851489
[TBL] [Abstract][Full Text] [Related]
2. Challenges in obtaining research ethics and governance approvals for an Australian national intersector, multisite audit study.
Buck K; Nolte L; Kelly H; Detering K; Sinclair C; White BP; Sellars M
Aust Health Rev; 2020 Sep; 44(5):799-805. PubMed ID: 32943137
[TBL] [Abstract][Full Text] [Related]
3. Inconsistencies and time delays in site-specific research approvals hinder collaborative clinical research in Australia.
White VM; Bibby H; Green M; Anazodo A; Nicholls W; Pinkerton R; Phillips M; Harrup R; Osborn M; Orme LM; Conyers R; Thompson K; Coory M
Intern Med J; 2016 Sep; 46(9):1023-9. PubMed ID: 27396473
[TBL] [Abstract][Full Text] [Related]
4. Multi-centre ethics and research governance review can impede non-interventional clinical research.
Duplancic C; Crough T; Bell SC;
Intern Med J; 2019 Jun; 49(6):722-728. PubMed ID: 30417974
[TBL] [Abstract][Full Text] [Related]
5. Ethical issues: the multi-centre low-risk ethics/governance review process and AMOSS.
Vaughan G; Pollock W; Peek MJ; Knight M; Ellwood D; Homer CS; Pulver LJ; McLintock C; Ho MT; Sullivan EA
Aust N Z J Obstet Gynaecol; 2012 Apr; 52(2):195-203. PubMed ID: 22188386
[TBL] [Abstract][Full Text] [Related]
6. Governance frameworks for COVID-19 research ethics review and oversight in Latin America: an exploratory study.
Palmero A; Carracedo S; Cabrera N; Bianchini A
BMC Med Ethics; 2021 Nov; 22(1):147. PubMed ID: 34742278
[TBL] [Abstract][Full Text] [Related]
7. Ethical dilemmas of a large national multi-centre study in Australia: time for some consistency.
Driscoll A; Currey J; Worrall-Carter L; Stewart S
J Clin Nurs; 2008 Aug; 17(16):2212-20. PubMed ID: 18705740
[TBL] [Abstract][Full Text] [Related]
8. Re: Variation in Human Research Ethics Committee and governance processes throughout Australia: a need for a uniform approach.
Stanley GHM; Wade RG; Potts S; Wilson N; Findlay M
ANZ J Surg; 2021 Nov; 91(11):2545. PubMed ID: 34766674
[No Abstract] [Full Text] [Related]
9. Trust and confidence: towards mutual acceptance of ethics committee approval of multicentre studies.
Sarson-Lawrence M; Alt C; Mok MT; Dodds M; Rosenthal MA
Intern Med J; 2004 Nov; 34(11):598-603. PubMed ID: 15546452
[TBL] [Abstract][Full Text] [Related]
10. Ethics and governance for a multi-site study in Australia: Navigating the snakes and ladders.
Samir N; Amarasena L; Sealy L; Hodgins M; Gelaw Y; Lingam R; Zwi K
J Paediatr Child Health; 2022 Jan; 58(1):16-23. PubMed ID: 34529302
[TBL] [Abstract][Full Text] [Related]
11. Ethical frameworks in clinical research processes during COVID-19: a scoping review.
Kasherman L; Madariaga A; Liu Q; Bonilla L; McMullen M; Liu SL; Wang L; Fazelzad R; Karakasis K; Heesters AM; Oza AM
BMJ Open; 2021 Jul; 11(7):e047076. PubMed ID: 34301656
[TBL] [Abstract][Full Text] [Related]
12. Rethinking the role of Research Ethics Committees in the light of Regulation (EU) No 536/2014 on clinical trials and the COVID-19 pandemic.
Tusino S; Furfaro M
Br J Clin Pharmacol; 2022 Jan; 88(1):40-46. PubMed ID: 33891323
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of Human Research Ethics Committees and Research Governance Offices across Australia: An observational study.
De Smit E; Kearns LS; Clarke L; Dick J; Hill CL; Hewitt AW
Australas Med J; 2016; 9(2):33-9. PubMed ID: 26989449
[TBL] [Abstract][Full Text] [Related]
14. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany.
Tilch K; Hopff SM; Appel K; Kraus M; Lorenz-Depiereux B; Pilgram L; Anton G; Berger S; Geisler R; Haas K; Illig T; Krefting D; Lorbeer R; Mitrov L; Muenchhoff M; Nauck M; Pley C; Reese JP; Rieg S; Scherer M; Stecher M; Stellbrink C; Valentin H; Winter C; Witzenrath M; Vehreschild JJ
BMC Med Ethics; 2023 Oct; 24(1):84. PubMed ID: 37848886
[TBL] [Abstract][Full Text] [Related]
15. Clinical investigation and informed consent form in times of COVID-19 pandemic. A vision from the committee ethics of research.
Cervera Barajas A; Saldaña Valderas M
Med Clin (Barc); 2021 Nov; 157(9):e307-e308. PubMed ID: 33288207
[No Abstract] [Full Text] [Related]
16. Ethics committees in the time of COVID-19.
Monaco E; Pisano L; Nasato L; Lorenzoni G; Gregori D; Martinato M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):113-118. PubMed ID: 33412801
[TBL] [Abstract][Full Text] [Related]
17. Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands.
Scott AM; Kolstoe S; Ploem MCC; Hammatt Z; Glasziou P
Health Res Policy Syst; 2020 Jan; 18(1):11. PubMed ID: 31992320
[TBL] [Abstract][Full Text] [Related]
18. Situation analysis of research ethics governance in Pakistan.
Jafarey A; Shekhani S; Raza F; Naz S
East Mediterr Health J; 2023 Jul; 29(7):500-507. PubMed ID: 37553736
[TBL] [Abstract][Full Text] [Related]
19. Ethical guidelines for deliberately infecting volunteers with COVID-19.
Richards AD
J Med Ethics; 2020 Aug; 46(8):502-504. PubMed ID: 32461245
[TBL] [Abstract][Full Text] [Related]
20. A Survey on Methodological Issues of Clinical Research Studies Reviewed by Independent Ethic Committees during the COVID-19 Pandemic in Italy.
Milanese A; Trerotoli P; Vestri A; On Behalf Of The Biostatisticians Collaborative Group And Sismec Directive Council
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]